In STEMI-patients, several factors may contribute to glycocalyx damage, that is, ischemia-reperfusion injury, shock, inflammation (TNF-α), hyperglycemia, atrial natriuretic peptide and oxidized low density lipoprotein (LDL). This evidence concerns the gene NPPA and Hyperglycemia.